Alzheimer’s Disease Iceland Study

November 19, 2012 // Alzheimers News

An Alzheimer’s disease study in Iceland has found a rare genetic mutation that increases the risk of the disease by as much as threefold. The gene mutation, in an immunoregulatory gene known as TREM2, is found in 1 out of every 200 patients studied. The findings “may generate new insights into the pathogenesis of late-onset Alzheimer’s disease,” wrote Dr. Harald Neumann of the University of Bonn in Germany and Dr. Mark J. Daly of Massachusetts General Hospital in Boston.

Read the full results of this study here: